Century Therapeutics Inc (IPSC) support and resistance · rev $6.6M
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
This page maps Century Therapeutics Inc (IPSC) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
IPSC currently screens at market cap $47.8M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new IPSC 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the IPSC quote page for the session range and the stock page for the full model.
Not investment advice.